| (HKD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 21.79B | 16.68% |
| Operating expense | — | — |
| Net income | 4.91B | 46.25% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 2269.HK returned +47.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +54.6% |
| 1 year | +47.6% |
| 5 years | -59.6% |
| All-time high | $142.30 (Jun 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 2269.HK would be worth today ›No. WuXi Biologics (Cayman) Inc. has not paid a dividend in the past 12 months.
WuXi Biologics (Cayman) Inc. is part of the Healthcare sector.
WuXi Biologics (Cayman) Inc. has a market cap of 199.56B HKD, based on the latest quote.
WuXi Biologics (Cayman) Inc. is scheduled to report earnings on Aug 25, 2026.
